Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy

Clinical trial NCT03887442 · TERMINATED

Trial details

NCT number: NCT03887442
Sponsor: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2011-02-16
Primary completion: 2012-10-02
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.